SQZ Biotech

SQZ Biotech is a privately held clinical-stage company dedicated to developing transformative cell therapy candidates for patients with cancer and other serious diseases. SQZ Biotech's proprietary cell engineering approach, CellSqueeze®, physically squeezes cells through microfluidic constrictions to temporarily disrupt the cell membrane, allowing desired cargo to diffuse into the cytoplasm before the membrane reseals. SQZ Biotech uses this method to deliver a wide range of biomaterials into various cell types to create multifunctional cell therapy candidates designed to direct specific immune responses. SQZ Biotech believes that the CellSqueeze® technology enables the development of rapidly scalable cell therapies that leverage natural physiology to enhance therapeutic outcomes while maintaining a favorable safety and tolerability profile. SQZ technology can provide treatment options for patients with a variety of diseases.